TickerGuard
Buy Day today: Neutral (47) Mixed market breadth · no major macro event
VCRE

Vicore Pharma Holding AB

Healthcare · Biotechnology

8.70$ -0.9% vs. previous close Closing price · As of: Oct 7, 2026

Statements

Balance Sheet

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Balance Sheet VCRE
Line item Q4 24 Q1 25 Q2 25 Q4 25 Q1 26 Q2 26
– -9.4% -9.9% +24.8% -11.6% -13.7%
– -9.5% -9.9% +24.8% -11.7% -13.8%
– -38.1% -50.9% +64.4% -34.7% +13.6%
– – – – – –
– -4.8% +8.2% +80.5% -29.9% -11.7%
– -5.5% +7.0% +78.3% -28.5% -13.7%
– +23.9% -20.9% +34.5% -13.6% -41.3%
– -9.7% -11.0% +20.6% -9.5% -13.9%
– – – – – –
– +0.0% +0.0% +20.0% +0.0% +0.0%

Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?